TradingView
kambach
9 Nis 2021 16:28

$JNJ will bounce - Dip opportunity Alış

NYSE:JNJ60
Johnson & JohnsonNYSE

Açıklama

⋅
I love JNJ long and believe that they are going to be fine with the recent COVID-related dip.

Their vaccine could do more damage than AstraZeneca's and governments will still buy it in order to herd the sheep.

You need to understand that JNJ is so much more than a vaccine company.

Expect this stock to go back up to the $167 level, as well as breaking the $170 level as well.

A great swing trade (buy covid dips), and I also love this long-term.

Lots of money to be made here!


*Not a financial advisor.

**Don't judge me on my winners. Judge me on my losers, because there are so few.
Trend AnalysisbuythedipJNJvaccineCoronavirus (COVID-19)
Yorumlar
malbach
⋅
👍
MarkWallace10
⋅
Nope
kambach
⋅
@MarkWallace10, talented guy...you know how to wait for news to break! good boy!
MarkWallace10
⋅
@kambach, you could have watched the news last week and knew this news was coming out learn the fundamentals before you post
kambach
⋅
@MarkWallace10, hahaha sounds good big guy. If a 5% dip matters this much to you, you must lose a lot of money. You do you, and I'll keep buying these dips when I feel the support coming!
MarkWallace10
⋅
@kambach, good luck lol
Daha Fazla